Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

RGC – Regencell Bioscience Holdings Ltd

RGC — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

1.42

Margin Of Safety %

Put/Call OI Ratio

1.08

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

20.19

Target Price

Analyst Recom

Performance Q

-17.41

Upside

-100.6%

Beta

1.79

Ticker: RGC




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-05-11RGC27.350.910.196604
2026-05-12RGC27.030.830.587119
2026-05-13RGC27.420.880.057064
2026-05-14RGC27.1650.830.187278
2026-05-15RGC28.50.840.177334
2026-05-18RGC27.791.090.344451
2026-05-19RGC27.171.091.184478
2026-05-20RGC27.821.100.414888
2026-05-21RGC27.361.101.624891
2026-05-22RGC25.761.201.275135
2026-05-26RGC24.241.220.345216
2026-05-27RGC23.981.192.285311
2026-05-28RGC24.071.221.455397
2026-05-29RGC23.911.190.025383
2026-06-02RGC23.31.160.335465
2026-06-03RGC23.751.130.035609
2026-06-04RGC22.21.121.135656
2026-06-05RGC20.071.110.815680
2026-06-08RGC21.671.080.115901
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-05-11RGC27.35- - -
2026-05-12RGC27.28- - -
2026-05-13RGC27.24- - -
2026-05-14RGC27.04- - -
2026-05-15RGC28.50- - -
2026-05-18RGC27.71- - -
2026-05-19RGC27.12- - -
2026-05-20RGC27.86- - -
2026-05-21RGC27.28- - -
2026-05-22RGC25.85- - -
2026-05-26RGC24.40- - -
2026-05-27RGC23.78- - -
2026-05-28RGC24.39- - -
2026-05-29RGC23.82- - -
2026-06-01RGC24.32- - -
2026-06-02RGC23.33- - -
2026-06-03RGC23.75- - -
2026-06-04RGC22.20- - -
2026-06-05RGC20.13- - -
2026-06-08RGC21.58- - -
2026-06-09RGC20.19- - -
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-05-11RGC0.00-7.461.48
2026-05-12RGC0.00-7.461.38
2026-05-13RGC0.00-7.461.38
2026-05-14RGC0.00-7.461.38
2026-05-15RGC0.00-7.461.38
2026-05-18RGC0.00-4.671.38
2026-05-19RGC0.00-4.671.38
2026-05-20RGC0.00-4.671.38
2026-05-21RGC0.00-4.671.38
2026-05-22RGC0.00-4.671.38
2026-05-26RGC0.0010.681.38
2026-05-27RGC0.0010.681.38
2026-05-28RGC0.0010.681.42
2026-05-29RGC0.0010.681.42
2026-06-02RGC0.0010.681.42
2026-06-03RGC0.0010.681.42
2026-06-04RGC0.0010.681.42
2026-06-05RGC0.0010.681.42
2026-06-08RGC0.0010.681.42
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

10.68

Beta

1.79

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

4

Growth Score

Sentiment Score

18

Actual DrawDown %

97.9

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

8659.92

P/Free Cash Flow

EPS

-0.01

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.93

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

RGC Healthcare
$21.39
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
12/20
Pullback
15/25
Volume
7/15
Valuation
6/20
TP/AR
2/10
Options
4/10
RSI
36.3
Range 1M
16.3%
Sup Dist
11.4%
🚀
Momentum Growth
Ride accelerating trends
N/A
27 /100
WEAK
Momentum
9/25
Growth
7/30
Estimates
0/20
Inst/Vol
7/15
Options
4/10
EPS Yr
0%
EPS NY
0%
52W%
16.2%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
Quality
2/30
Valuation
2/30
Growth
3/25
Stability
5/10
LT Trend
4/5
Quality
4
Regencell Bioscience Holdings L
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 10
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
RGC

Latest News

Caricamento notizie per RGC
stock quote shares RGC – Regencell Bioscience Holdings Ltd Stock Price stock today
news today RGC – Regencell Bioscience Holdings Ltd stock forecast ,stock prediction 2023 2024 2025
marketwatch RGC – Regencell Bioscience Holdings Ltd yahoo finance google finance
stock history RGC – Regencell Bioscience Holdings Ltd invest stock market
stock prices RGC premarket after hours
ticker RGC fair value insiders trading

SIMO – Silicon Motion Technology Corporation

SIMO — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

1.88

Margin Of Safety %

Put/Call OI Ratio

0.46

EPS Next Q Diff

0.31

EPS Last/This Y

5.07

EPS This/Next Y

0.96

Price

259.75

Target Price

283.38

Analyst Recom

1

Performance Q

116.4

Upside

-33.1%

Beta

1.74

Ticker: SIMO




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-05-11SIMO262.270.350.2627895
2026-05-12SIMO259.070.350.1234655
2026-05-13SIMO270.250.350.4034882
2026-05-14SIMO264.160.360.8535105
2026-05-15SIMO259.960.371.1035646
2026-05-18SIMO239.930.240.2523643
2026-05-19SIMO252.920.280.2124786
2026-05-20SIMO258.270.370.4826755
2026-05-21SIMO261.610.370.3927011
2026-05-22SIMO276.540.370.1627339
2026-05-26SIMO290.30.350.7229005
2026-05-27SIMO285.030.400.5931250
2026-05-28SIMO282.430.410.7232120
2026-05-29SIMO276.880.430.4432564
2026-06-02SIMO301.60.460.2232276
2026-06-03SIMO306.240.470.4532633
2026-06-04SIMO295.280.460.1632959
2026-06-05SIMO257.570.460.1433300
2026-06-08SIMO263.190.460.7333328
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-05-11SIMO262.08206.8- 8.71
2026-05-12SIMO259.34206.8- 8.71
2026-05-13SIMO270.06206.8- 8.71
2026-05-14SIMO263.98206.8- 8.71
2026-05-15SIMO259.71206.8- 8.71
2026-05-18SIMO239.57206.8- 8.71
2026-05-19SIMO252.98206.8- 8.71
2026-05-20SIMO258.18206.8- 8.71
2026-05-21SIMO264.13206.8- 8.71
2026-05-22SIMO276.51206.8- 8.71
2026-05-26SIMO290.14206.8- 8.71
2026-05-27SIMO285.27206.8- 8.71
2026-05-28SIMO282.19206.8- 8.71
2026-05-29SIMO276.70206.8- 8.71
2026-06-01SIMO268.18206.8- 8.71
2026-06-02SIMO296.45206.8- 8.71
2026-06-03SIMO306.32206.8- 8.71
2026-06-04SIMO294.81206.8- 8.71
2026-06-05SIMO257.56206.8- 8.71
2026-06-08SIMO263.16206.8- 8.71
2026-06-09SIMO259.75206.8- 8.71
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-05-11SIMO-0.930.540.93
2026-05-12SIMO-0.940.541.54
2026-05-13SIMO-0.940.541.54
2026-05-14SIMO-0.940.541.54
2026-05-15SIMO-0.940.541.54
2026-05-18SIMO-0.943.311.54
2026-05-19SIMO-0.943.311.54
2026-05-20SIMO-0.943.311.54
2026-05-21SIMO-0.943.311.54
2026-05-22SIMO-0.943.311.54
2026-05-26SIMO-0.94-0.281.54
2026-05-27SIMO-0.94-0.281.54
2026-05-28SIMO-0.94-0.281.89
2026-05-29SIMO-0.94-0.281.89
2026-06-02SIMO-0.94-0.261.89
2026-06-03SIMO-0.94-0.261.89
2026-06-04SIMO-0.94-0.261.89
2026-06-05SIMO-0.94-0.261.89
2026-06-08SIMO-0.94-0.381.88
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

1.97

Avg. EPS Est. Current Quarter

2.12

Avg. EPS Est. Next Quarter

2.28

Insider Transactions

-0.94

Institutional Transactions

-0.38

Beta

1.74

Average Sales Estimate Current Quarter

403

Average Sales Estimate Next Quarter

429

Fair Value

Quality Score

84

Growth Score

96

Sentiment Score

87

Actual DrawDown %

17.4

Max Drawdown 5-Year %

-56.5

Target Price

283.38

P/E

52.35

Forward P/E

25.64

PEG

0.53

P/S

8.32

P/B

9.75

P/Free Cash Flow

EPS

5.03

Average EPS Est. Cur. Y​

8.71

EPS Next Y. (Est.)

9.67

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

15.99

Relative Volume

0.88

Return on Equity vs Sector %

-35.5

Return on Equity vs Industry %

-39.6

EPS 1 7Days Diff

8.7

EPS 1 30Days Diff

3.06

EBIT Estimation

SIMO Technology
$263.21
📉
Swing / Pullback
Buy the dip on strong trends
39 /100
WEAK
Trend
2/20
Pullback
13/25
Volume
7/15
Valuation
6/20
TP/AR
6/10
Options
5/10
RSI
53.4
Range 1M
37.3%
Sup Dist
5.9%
🚀
Momentum Growth
Ride accelerating trends
N/A
53 /100
WEAK
Momentum
5/25
Growth
27/30
Estimates
13/20
Inst/Vol
4/15
Options
4/10
EPS Yr
146.4%
EPS NY
17.4%
52W%
78.7%
💎
Long-Term Value
Quality companies, undervalued
56 /100
WATCH
🟡 HOLD +22.6% upside
Quality
17/30
Valuation
8/30
Growth
22/25
Stability
8/10
LT Trend
1/5
Upside
+22.6%
Quality
84
Silicon Motion Technology Corpo
Sector: Technology
Industry: Semiconductors
Employees: 2009
Silicon Motion Technology Corporation, together with its subsidiaries, designs, develops, and markets NAND flash controllers for solid-state storage devices and related devices in China, Japan, Singapore, Taiwan, Korea, the United States, and internationally. It offers controllers for computing-grade solid state drives (SSDs), which are used in PCs and other client devices; enterprise-grade SSDs used in enterprise and hyperscale data centers; eMMC and UFS mobile embedded storage for use in smartphones and IoT devices; flash memory cards and flash drives for use in expandable storage; and specialized SSDs that are used in industrial, commercial, and automotive applications. The company markets its controllers under the SMI brand; and single-chip SSDs under the FerriSSD, Ferri-eMMC, and Ferri-UFS brands. It markets and sells its products through direct sales personnel and independent electronics distributors to NAND flash makers, module makers, hyperscalers, and OEMs. Silicon Motion Technology Corporation was founded in 1995 and is based in Hong Kong, Hong Kong.
SIMO

Latest News

Caricamento notizie per SIMO
stock quote shares SIMO – Silicon Motion Technology Corporation Stock Price stock today
news today SIMO – Silicon Motion Technology Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch SIMO – Silicon Motion Technology Corporation yahoo finance google finance
stock history SIMO – Silicon Motion Technology Corporation invest stock market
stock prices SIMO premarket after hours
ticker SIMO fair value insiders trading

NHTC – Natural Health Trends Corp.

NHTC — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

0.35

Margin Of Safety %

Put/Call OI Ratio

1.29

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

2.29

Target Price

Analyst Recom

Performance Q

-27.07

Upside

-156.8%

Beta

0.85

Ticker: NHTC




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-05-11NHTC3.171.321.50338
2026-05-12NHTC3.031.321.50338
2026-05-13NHTC2.881.44999.99346
2026-05-14NHTC2.931.44999.99346
2026-05-15NHTC2.811.45999.99348
2026-05-18NHTC2.791.350.00327
2026-05-19NHTC2.771.320.00330
2026-05-20NHTC2.851.320.00330
2026-05-21NHTC2.881.30999.99333
2026-05-22NHTC2.821.30999.99333
2026-05-26NHTC2.751.30999.99333
2026-05-27NHTC2.721.30999.99333
2026-05-28NHTC2.821.30999.99333
2026-05-29NHTC2.75N/AN/A0
2026-06-02NHTC2.581.300.00334
2026-06-03NHTC2.391.290.00336
2026-06-04NHTC2.431.290.00336
2026-06-05NHTC2.341.290.00336
2026-06-08NHTC2.291.290.00336
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-05-11NHTC3.20- - -
2026-05-12NHTC3.04- - -
2026-05-13NHTC2.88- - -
2026-05-14NHTC2.91- - -
2026-05-15NHTC2.82- - -
2026-05-18NHTC2.78- - -
2026-05-19NHTC2.78- - -
2026-05-20NHTC2.86- - -
2026-05-21NHTC2.86- - -
2026-05-22NHTC2.83- - -
2026-05-26NHTC2.78- - -
2026-05-27NHTC2.72- - -
2026-05-28NHTC2.75- - -
2026-05-29NHTC2.76- - -
2026-06-01NHTC2.64- - -
2026-06-02NHTC2.57- - -
2026-06-03NHTC2.39- - -
2026-06-04NHTC2.44- - -
2026-06-05NHTC2.34- - -
2026-06-08NHTC2.29- - -
2026-06-09NHTC2.29- - -
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-05-11NHTC0.00-19.760.33
2026-05-12NHTC0.00-19.760.39
2026-05-13NHTC0.00-19.760.39
2026-05-14NHTC0.00-19.760.39
2026-05-15NHTC0.00-19.760.39
2026-05-18NHTC0.00-19.750.39
2026-05-19NHTC0.00-19.750.39
2026-05-20NHTC0.00-19.750.39
2026-05-21NHTC0.00-19.750.39
2026-05-22NHTC0.00-19.750.39
2026-05-26NHTC0.00-1.290.39
2026-05-27NHTC0.00-1.290.39
2026-05-28NHTC0.00-1.290.35
2026-05-29NHTC0.00-1.290.35
2026-06-02NHTC0.00-4.760.35
2026-06-03NHTC0.00-4.760.35
2026-06-04NHTC0.00-4.760.35
2026-06-05NHTC0.00-4.760.35
2026-06-08NHTC0.00-4.760.35
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-4.76

Beta

0.85

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

44

Growth Score

26

Sentiment Score

30

Actual DrawDown %

72.2

Max Drawdown 5-Year %

-72.1

Target Price

P/E

Forward P/E

PEG

P/S

0.51

P/B

1.19

P/Free Cash Flow

EPS

-0.1

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-3.03

Relative Volume

1.14

Return on Equity vs Sector %

-25.3

Return on Equity vs Industry %

-27.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

NHTC Consumer Cyclical
$2.29
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
20/20
Pullback
5/25
Volume
4/15
Valuation
6/20
TP/AR
2/10
Options
3/10
RSI
27.9
Range 1M
2%
🚀
Momentum Growth
Ride accelerating trends
N/A
28 /100
WEAK
Momentum
17/25
Growth
4/30
Estimates
1/20
Inst/Vol
2/15
Options
4/10
EPS Yr
0%
EPS NY
0%
52W%
0.7%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
Quality
6/30
Valuation
2/30
Growth
0/25
Stability
7/10
LT Trend
4/5
Quality
44
Natural Health Trends Corp.
Sector: Consumer Cyclical
Industry: Internet Retail
Employees: 118
Natural Health Trends Corp., a direct-selling and e-commerce company, provides personal care, wellness, and lifestyle products under the NHT Global brand. The company offers wellness products, such as liquid, encapsulated, tableted and powder dietary and nutritional supplements, vitamins, and minerals; and herbal products, including herbal supplements. It also provides beauty products comprising facial skin care, hand and body care, age-defying and hydrating cleansers, creams, lotions, serums, and toners; and lifestyle products consisting of weight management and energy enhancing supplements, as well as topical gels. In addition, the company offers at-home testing kits for measuring critical biomarkers of well-being, including cardiovascular, hormonal, inflammatory, metabolic, and nutritional health. It sells its products directly to consumers, as well as through an e-commerce retail platform in the United States, Canada, the Cayman Islands, Mexico, Peru, and Colombia; Hong Kong, Taiwan, and China; Malaysia and Singapore; South Korea; Russia and Kazakhstan; Japan; India; and Europe. The company was formerly known as Florida Institute of Massage Therapy, Inc. and changed its name to Natural Health Trends Corp. in June 1993. Natural Health Trends Corp. was incorporated in 1988 and is headquartered in Rolling Hills Estates, California.
NHTC

Latest News

Caricamento notizie per NHTC
stock quote shares NHTC – Natural Health Trends Corp. Stock Price stock today
news today NHTC – Natural Health Trends Corp. stock forecast ,stock prediction 2023 2024 2025
marketwatch NHTC – Natural Health Trends Corp. yahoo finance google finance
stock history NHTC – Natural Health Trends Corp. invest stock market
stock prices NHTC premarket after hours
ticker NHTC fair value insiders trading

MSC – Studio City International Holdings Ltd ADR

MSC — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

2.21

Target Price

11

Analyst Recom

1

Performance Q

-21.23

Upside

-221.9%

Beta

0.1

Ticker: MSC




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-05-11MSC2.5N/AN/A0
2026-05-12MSC2.4N/AN/A0
2026-05-13MSC2.46N/AN/A0
2026-05-14MSC2.44N/AN/A0
2026-05-15MSC2.52N/AN/A0
2026-05-18MSC2.46N/AN/A0
2026-05-19MSC2.46N/AN/A0
2026-05-20MSC2.33N/AN/A0
2026-05-21MSC2.47N/AN/A0
2026-05-22MSC2.4N/AN/A0
2026-05-26MSC2.34N/AN/A0
2026-05-27MSC2.33N/AN/A0
2026-05-28MSC2.34N/AN/A0
2026-05-29MSC2.36N/AN/A0
2026-06-02MSC2.3N/AN/A0
2026-06-03MSC2.29N/AN/A0
2026-06-04MSC2.27N/AN/A0
2026-06-05MSC2.27N/AN/A0
2026-06-08MSC2.34N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-05-11MSC2.40- - -
2026-05-12MSC2.32- - -
2026-05-13MSC2.51- - -
2026-05-14MSC2.52- - -
2026-05-15MSC2.50- - -
2026-05-18MSC2.46- - -
2026-05-19MSC2.44- - -
2026-05-20MSC2.37- - -
2026-05-21MSC2.34- - -
2026-05-22MSC2.40- - -
2026-05-26MSC2.34- - -
2026-05-27MSC2.34- - -
2026-05-28MSC2.34- - -
2026-05-29MSC2.38- - -
2026-06-01MSC2.39- - -
2026-06-02MSC2.30- - -
2026-06-03MSC2.30- - -
2026-06-04MSC2.30- - -
2026-06-05MSC2.27- - -
2026-06-08MSC2.29- - -
2026-06-09MSC2.21- - -
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-05-11MSC04.340.00
2026-05-12MSC04.340.00
2026-05-13MSC04.340.00
2026-05-14MSC04.340.00
2026-05-15MSC04.340.00
2026-05-18MSC03.950.00
2026-05-19MSC03.950.00
2026-05-20MSC03.950.00
2026-05-21MSC03.950.00
2026-05-22MSC03.950.00
2026-05-26MSC00.010.00
2026-05-27MSC00.010.00
2026-05-28MSC00.010.00
2026-05-29MSC00.010.00
2026-06-02MSC00.010.00
2026-06-03MSC00.010.00
2026-06-04MSC00.010.00
2026-06-05MSC00.010.00
2026-06-08MSC00.010.00
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

0.01

Beta

0.1

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

54

Growth Score

60

Sentiment Score

89

Actual DrawDown %

86

Max Drawdown 5-Year %

-88.1

Target Price

11

P/E

Forward P/E

PEG

P/S

0.61

P/B

0.94

P/Free Cash Flow

EPS

-0.21

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-5.63

Relative Volume

0.13

Return on Equity vs Sector %

-25.5

Return on Equity vs Industry %

-37.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

MSC Consumer Cyclical
$2.24
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
0/20
Pullback
20/25
Volume
11/15
Valuation
12/20
TP/AR
2/10
Options
0/10
RSI
40.9
Range 1M
14.4%
Sup Dist
0.4%
🚀
Momentum Growth
Ride accelerating trends
N/A
16 /100
WEAK
Momentum
0/25
Growth
11/30
Estimates
3/20
Inst/Vol
2/15
Options
0/10
EPS Yr
0%
EPS NY
0%
52W%
5.3%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +391.1% upside
Quality
5/30
Valuation
17/30
Growth
4/25
Stability
2/10
LT Trend
1/5
Upside
+391.1%
Quality
54
Studio City International Holdi
Sector: Consumer Cyclical
Industry: Resorts & Casinos
Employees: 5879
Studio City International Holdings Limited provides provision of services pursuant to a casino contract and the hospitality business in Macau. It operates gaming services, a casino contract for the operation of studio city casino, focusing on mass market and premium mass market table games and gaming machines, including baccarat, three-card baccarat, blackjack, craps, caribbean stud poker, roulette, sic bo, fortune 3 card poker, and other games; hospitality services; dining services; event and convention services; other services; leasing services; and resort, which offers various non-gaming attractions, including figure-8 ferris wheel, nightclub and karaoke venue, live performance arena, and an outdoor and indoor water park, as well as live performance arena and various food and beverage establishments, and retail space. The company was formerly known as Cyber One Agents Limited and changed its name to Studio City International Holdings Limited in January 2012. The company was founded in 2000 and is based in Central, Hong Kong. Studio City International Holdings Limited is a subsidiary of MCO Cotai Investments Limited.
MSC

Latest News

Caricamento notizie per MSC
stock quote shares MSC – Studio City International Holdings Ltd ADR Stock Price stock today
news today MSC – Studio City International Holdings Ltd ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch MSC – Studio City International Holdings Ltd ADR yahoo finance google finance
stock history MSC – Studio City International Holdings Ltd ADR invest stock market
stock prices MSC premarket after hours
ticker MSC fair value insiders trading

FUTU – Futu Holdings Limited

FUTU — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

3.59

Margin Of Safety %

Put/Call OI Ratio

1.3

EPS Next Q Diff

EPS Last/This Y

60.49

EPS This/Next Y

25.86

Price

91.37

Target Price

228.42

Analyst Recom

1.1

Performance Q

-4.75

Upside

N/A

Beta

0.5

Ticker: FUTU




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-05-11FUTU139.92.232.9294912
2026-05-12FUTU136.962.251.74100892
2026-05-13FUTU142.662.212.12106928
2026-05-14FUTU141.542.224.97113230
2026-05-15FUTU134.782.422.56125435
2026-05-18FUTU131.652.482.29108840
2026-05-19FUTU124.32.544.19117593
2026-05-20FUTU124.772.574.84127230
2026-05-21FUTU123.842.689.06137011
2026-05-22FUTU89.463.242.06166385
2026-05-26FUTU107.731.630.70154014
2026-05-27FUTU110.461.610.80174931
2026-05-28FUTU104.91.530.75188163
2026-05-29FUTU104.141.380.81195280
2026-06-02FUTU101.951.491.07165784
2026-06-03FUTU96.321.461.25169929
2026-06-04FUTU95.851.351.40168953
2026-06-05FUTU92.331.301.94169950
2026-06-08FUTU91.021.301.37146297
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-05-11FUTU139.9133.9- 96.11
2026-05-12FUTU136.9033.9- 95.40
2026-05-13FUTU142.7333.9- 95.40
2026-05-14FUTU141.5033.9- 95.40
2026-05-15FUTU134.6533.9- 95.40
2026-05-18FUTU131.7433.9- 95.40
2026-05-19FUTU124.4233.9- 95.40
2026-05-20FUTU124.7633.9- 95.40
2026-05-21FUTU123.7933.9- 95.40
2026-05-22FUTU89.7033.9- 95.40
2026-05-26FUTU107.7633.9- 93.96
2026-05-27FUTU110.2633.9- 93.96
2026-05-28FUTU104.9233.9- 93.96
2026-05-29FUTU104.1933.9- 93.96
2026-06-01FUTU102.8133.9- 93.96
2026-06-02FUTU101.6533.9- 93.96
2026-06-03FUTU96.1937.1- 71.56
2026-06-04FUTU95.7337.1- 71.56
2026-06-05FUTU92.3537.1- 70.87
2026-06-08FUTU91.0237.1- 70.87
2026-06-09FUTU91.3737.1- 70.87
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




No data found

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

25.85

Avg. EPS Est. Next Quarter

30.24

Insider Transactions

Institutional Transactions

-3.83

Beta

0.5

Average Sales Estimate Current Quarter

5934

Average Sales Estimate Next Quarter

5799

Fair Value

Quality Score

80

Growth Score

100

Sentiment Score

24

Actual DrawDown %

54.9

Max Drawdown 5-Year %

-86.4

Target Price

228.42

P/E

15.05

Forward P/E

11.06

PEG

0.68

P/S

5.06

P/B

4.22

P/Free Cash Flow

EPS

10.29

Average EPS Est. Cur. Y​

70.87

EPS Next Y. (Est.)

96.73

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

49.62

Relative Volume

0.27

Return on Equity vs Sector %

12.6

Return on Equity vs Industry %

9.9

EPS 1 7Days Diff

-23.1

EPS 1 30Days Diff

-25.24

EBIT Estimation

Futu Holdings Limited
Sector: Financial Services
Industry: Capital Markets
Employees: 3540
Futu Holdings Limited engages in the provision of digitalized securities brokerage and wealth management product distribution service in Hong Kong and internationally. It offers online financial services, including securities and derivative trades brokerage, margin financing and fund distribution services through its Futubull and Moomoo digital platforms. The company also provides financial information and online community services; online wealth management services under the Money Plus brand name through its Futubull and moomoo platforms, which provides its client access to mutual funds, private funds, bonds, structured products, and other wealth management products; market data and information services; and NiuNiu Community, an open forum for users and clients to share insights, ask questions, and exchange ideas. Futu Holdings Limited was founded in 2007 and is headquartered in Admiralty, Hong Kong.
FUTU

Latest News

Caricamento notizie per FUTU
stock quote shares FUTU – Futu Holdings Limited Stock Price stock today
news today FUTU – Futu Holdings Limited stock forecast ,stock prediction 2023 2024 2025
marketwatch FUTU – Futu Holdings Limited yahoo finance google finance
stock history FUTU – Futu Holdings Limited invest stock market
stock prices FUTU premarket after hours
ticker FUTU fair value insiders trading

HCM – HUTCHMED (China) Limited

HCM — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

0.13

Margin Of Safety %

Put/Call OI Ratio

1.33

EPS Next Q Diff

EPS Last/This Y

-2.27

EPS This/Next Y

0.11

Price

10.58

Target Price

20.81

Analyst Recom

1.39

Performance Q

-21.21

Upside

745.2%

Beta

0.24

Ticker: HCM




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-05-11HCM12.810.390.00341
2026-05-12HCM12.670.390.00341
2026-05-13HCM12.750.390.00341
2026-05-14HCM12.690.60999.99257
2026-05-15HCM12.530.590.73256
2026-05-18HCM11.940.87999.9986
2026-05-19HCM11.971.02999.9993
2026-05-20HCM11.971.04999.9994
2026-05-21HCM11.971.04999.9994
2026-05-22HCM11.981.04999.9994
2026-05-26HCM11.751.370.00109
2026-05-27HCM11.721.370.00109
2026-05-28HCM11.161.370.00109
2026-05-29HCM11.371.375.00109
2026-06-02HCM11.531.375.00109
2026-06-03HCM11.251.375.00109
2026-06-04HCM11.171.375.00109
2026-06-05HCM10.861.330.00119
2026-06-08HCM10.871.330.00119
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-05-11HCM12.87- -492.70.38
2026-05-12HCM12.69- -492.70.38
2026-05-13HCM12.76- -492.80.38
2026-05-14HCM12.69- -491.20.38
2026-05-15HCM12.50- -492.10.38
2026-05-18HCM11.97- -492.70.38
2026-05-19HCM12.00- -491.70.38
2026-05-20HCM11.87- -492.40.38
2026-05-21HCM12.02- -491.00.38
2026-05-22HCM12.04- -492.30.38
2026-05-26HCM11.73- -492.50.38
2026-05-27HCM11.70- -492.10.38
2026-05-28HCM11.16- -493.40.38
2026-05-29HCM11.34- -491.80.38
2026-06-01HCM11.43- -490.70.38
2026-06-02HCM11.55- -490.30.38
2026-06-03HCM11.33- -490.80.38
2026-06-04HCM11.20- -490.70.38
2026-06-05HCM10.86- -492.50.38
2026-06-08HCM10.81- -490.70.38
2026-06-09HCM10.58- -493.10.38
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-05-11HCM0.00-2.370.18
2026-05-12HCM0.00-2.370.15
2026-05-13HCM0.00-2.370.15
2026-05-14HCM0.00-2.370.15
2026-05-15HCM0.00-2.370.15
2026-05-18HCM0.00-2.670.15
2026-05-19HCM0.00-2.670.15
2026-05-20HCM0.00-2.670.15
2026-05-21HCM0.00-2.670.15
2026-05-22HCM0.00-2.670.15
2026-05-26HCM0.00-1.660.15
2026-05-27HCM0.00-1.660.15
2026-05-28HCM0.00-1.660.13
2026-05-29HCM0.00-1.660.13
2026-06-02HCM0.00-12.280.13
2026-06-03HCM0.00-12.280.13
2026-06-04HCM0.00-12.280.13
2026-06-05HCM0.00-12.280.13
2026-06-08HCM0.00-12.700.13
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-12.7

Beta

0.24

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

99

Growth Score

62

Sentiment Score

43

Actual DrawDown %

75.9

Max Drawdown 5-Year %

-82.2

Target Price

20.81

P/E

4.14

Forward P/E

24.07

PEG

P/S

3.44

P/B

1.53

P/Free Cash Flow

EPS

2.62

Average EPS Est. Cur. Y​

0.38

EPS Next Y. (Est.)

0.49

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

83.28

Relative Volume

0.89

Return on Equity vs Sector %

9.4

Return on Equity vs Industry %

28.9

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-493.1
HCM Healthcare
$10.85
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
14/20
Pullback
13/25
Volume
7/15
Valuation
15/20
TP/AR
2/10
Options
2/10
RSI
22.1
Range 1M
6.2%
Sup Dist
1.4%
🚀
Momentum Growth
Ride accelerating trends
N/A
32 /100
WEAK
Momentum
10/25
Growth
13/30
Estimates
5/20
Inst/Vol
0/15
Options
4/10
EPS Yr
-87.7%
EPS NY
40.5%
52W%
1.7%
💎
Long-Term Value
Quality companies, undervalued
59 /100
WATCH
🟢 BUY +67.7% upside
Quality
25/30
Valuation
16/30
Growth
8/25
Stability
6/10
LT Trend
4/5
Upside
+67.7%
Quality
99
HUTCHMED (China) Limited
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 1796
HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally. It provides Fruquintinib, a selective and potent oral inhibitor of vascular endothelial growth factor receptors for treatment of colorectal cancer (CRC), breast cancer, gastric cancer (GC), microsatellite stable-CRC endometrial cancer (EMC), non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), endometrial cancer (EMC); and Savolitinib, a potent and selective inhibitor of mesenchymal-epithelial transition receptor to treat NSCLC, papillary RCC, and GC. It also develops Surufatinib to treat pancreatic neuroendocrine tumor (NET), non pancreatic NET, and pancreatic ductal adenocarcinoma; Sovleplenib, to treat immune thrombocytopenic purpura and warm autoimmune hemolytic anemia; and Tazemetostat, a treatment for epithelioid sarcoma and follicular lymphoma; Fanregratinib that treats intrahepatic cholangiocarcinoma; and Ranosidenib, a novel dual-inhibitor of dehydrogenase-1 and isocitrate dehydrogenase-2 enzymes to treat acute myeloid leukemia (AML). In addition, the company is developing HMPL-760, which is in phase I and II clinical trial to treat relapsed and/or refractory diffuse large B cell lymphoma, chronic lymphocytic leukemia, small lymphocytic lymphoma, and other B-NHL; HMPL-506 to treat Mixed-lineage leukemia-rearrange/rearrangement and nucleophosmin 1-mutantAML. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., and Epizyme, Inc., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.
HCM

Latest News

Caricamento notizie per HCM
stock quote shares HCM – HUTCHMED (China) Limited Stock Price stock today
news today HCM – HUTCHMED (China) Limited stock forecast ,stock prediction 2023 2024 2025
marketwatch HCM – HUTCHMED (China) Limited yahoo finance google finance
stock history HCM – HUTCHMED (China) Limited invest stock market
stock prices HCM premarket after hours
ticker HCM fair value insiders trading
No more stocks to show